Patent details

Basic Information

Publication number:

EP3223822

PCT Application Number:

US2015062826

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP158642090

PCT Publication Number:

WO2016086218

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BILE ACID DERIVATIVES AS FXR/TGR5 AGONISTS

French Title of Invention:

DÉRIVÉS D'ACIDE BILIAIRE UTILISÉS COMME AGONISTES DE FXR/TGR5

German Title of Invention:

GALLENSÄUREDERIVATE ALS FXR/TGR5-AGONISTEN

SPC Number:

Dates

Filing date:

27/11/2015

Grant date:

01/07/2020

EP Publication Date:

04/10/2017

PCT Publication Date:

02/06/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

01/07/2020

EP B1 Publication Date:

01/07/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

27/11/2023

Expiration date:

27/11/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

24/06/2020

 

 

Name:

Enanta Pharmaceuticals, Inc.

Address:

500 Arsenal Street, Watertown, MA 02472, United States (US)

Agent

Name:

COSMOVICI INTELLECTUAL PROPERTY SARL

From:

18/08/2020

Address:

11, Boulevard Sébastopol, 75001, Paris, France (FR)

To:

Inventor

1

Name:

XING, Xuechao

Address:

United States (US)

2

Name:

DAI, Peng

Address:

United States (US)

3

Name:

SHEN, Ruichao

Address:

United States (US)

4

Name:

WANG, Guoqiang

Address:

United States (US)

5

Name:

HE, Jing

Address:

United States (US)

6

Name:

OR, Yat Sun

Address:

United States (US)

7

Name:

LONG, Jiang

Address:

United States (US)

Priority

1

Priority Number:

201462084769 P

Priority Date:

26/11/2014

Priority Country:

United States (US)

2

Priority Number:

201562103374 P

Priority Date:

14/01/2015

Priority Country:

United States (US)

3

Priority Number:

201514951989

Priority Date:

25/11/2015

Priority Country:

United States (US)

Classification

IPC classification:

A61K 31/56; A61P 1/16; A61P 3/04; A61P 3/06; A61P 3/10; C07J 9/00; C07J 41/00; C07J 43/00; C07J 51/00;

Publication

European Patent Bulletin

Issue number:

202027

Publication date:

01/07/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

14/11/2022

Last Annual Fee Paid Number:

8

Last Annual Fee Paid Amount:

99 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages
19/08/2020	Outgoing Correspondence	1
18/08/2020	Power Of Attorney	1